Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    NCT00956410

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
Condition: Alzheimer Disease
Intervention: Biological: CAD106
To Top

† Indicates status has not been verified in more than two years